Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration

European Journal of Pharmacology

Volumn 641, Issue 2-3, 2010, Pages 128-134

  Ducharme, Nicole ^a,b   Banks, William A ^b,c   Morley, John E ^a,b   Robinson, Sandra M ^a,b   Niehoff, Michael L ^a,b   Mattern, Claudia ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d M et P Pharma AG   (Switzerland)

Author keywords

Anxiety; Intranasal; Memory; Neurosteroid; Pregnenolone; Progesterone

Indexed keywords

PREGNENOLONE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BRAIN LEVEL; DRUG DEGRADATION; DRUG STABILITY; DRUG UPTAKE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ANIMALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; BRAIN; CENTRAL NERVOUS SYSTEM; HIPPOCAMPUS; HYPOTHALAMUS; INJECTIONS, INTRAVENOUS; MALE; MICE; NEUROTRANSMITTER AGENTS; PREGNENOLONE; PROGESTERONE;

EID: 77954088381     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.033     Document Type: Article

References (33)

1. Andréen L., Nyberg S., Turkmen S., van Wingen G., Ferández G., Bäckström T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 2009, 34:1121-1132.
2. Banks W.A., During M.J., Niehoff M.L. Brain uptake of glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. J. Pharmacol. Exp. Ther. 2004, 309:469-475.
3. Banks W.A., Morley J.E., Niehoff M.L., Mattern C. Delivery of testosterone to the brain by intranasal administration: comparison to intravenous testosterone. J. Drug Target 2009, 17:759-765.
4. Baulieu E.-E., Robel P. Neurosteroids: a new brain function?. J. Steroid Chem. Mol. Biol. 1990, 37:395-403.
5. Bitran D., Shiekh M., Mcleod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABA(A) receptors. J. Neuroendocrinol. 1995, 7:171-177.
6. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J., Finch C.E., Morgan T.E., Pike C.J., Mack W.J., Stanczyk R.Z., Nilsen J. Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 2008, 29:313-339.
7. Brittebo E.B., Rafter J.J. Steroid metabolism by rat nasal mucosa: studies on progesterone and testosterone. J. Steroid Biochem. 1984, 20:1147-1151.
8. Collier T.L., Waterhouse R.N., Kassiou M. Imaging sigma receptors: applications in drug development. Current Pharm. Design 2007, 13:51-72.
9. de Souza Silva M.A., Topic B., Huston J.P., Mattern C. Intranasal administration of progesterone increases dopaminergic activity in amygdala and neostriatum of male rats. Neuroscience 2008, 157:196-203.
10. During M.J., Cao L., Zuzga D.S., Francis J.S., Fitzsimons H.L., Jiao X., Bland R.J., Klugmann M., Banks W.A., Drucker D.J., Haile C.N. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med. 2003, 9:1173-1179.
11. Eser D., Baghai T.C., Schuele C., Nothdurfter C., Ruppercht R. Neuroactive steroids as endogenous modulators of anxiety. Current Pharm. Design 2008, 14:3225-3253.
12. Farr,S.A., Flood,J.F., Scherrer,J.F., Kaiser,F.E., Taylor,G.T., Morley,J.E., 58 A.D. Effect of ovarian steroids on footshock avoidance learning and retention in female mice. Physiol. Behav. 58, 715-723.
13. Flood J.F., Morley J.E., Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1567-1571.
14. Guerra-Araiza C. Progesterone receptor isoforms expression in the prepuberal and adult male rat brain. Brain Res. Bull. 2001, 54:13-17.
15. Guerra-Araiza C. Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res. Bull. 2002, 59:105-109.
16. Gyermek L., Genther G., Fleming N. Some effects of progesterone and related steroids on the central nervous system. Int. J. Neuropharmacol. 1967, 6:191-198.
17. Korneyev A. Regional and interspecies differences in brain progesterone metabolism. J. Neurochem. 1993, 61:2041-2047.
18. Kumar T.C.A., David G.F.X., Sankaranarayanan A., Puri V., Sundram K.R. Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying. Proc. Nat. Acad. Sci. U. S. A. 1982, 79:4185-4189.
19. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 1987, 92:180-185.
20. Marynick S.P., Haven W.W., Ebert M.H., Loriaux D.L. Studies on the transfer of steroid hormones across the blood-cerebrospinal fluid barrier in Rhesus monkey. Endocrinology 1976, 99:400-405.
21. Meyer D.A., Carta M., Partridge L.D., Covey D.F., Valenzuela C.F. Neurosteroids enhance spontaneous release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors. J. Biol. Chem. 2002, 277:28725-28732.
22. Morley J.E., Levine A.S., Grace M., Kneip J., Gosnell B.A. The effect of ovariectomy, estradiol and progesterone on opioid modulation of feeding. Physiol. Behav. 1984, 33:237-241.
23. Nonaka N., Farr S.A., Kageyama H., Shioda S., Banks W.A. Delivery of galanin-like peptide to the brain: Targeting with intranasal delivery and cyclodextrins. J. Pharmacol. Exp. Ther. 2008, 325:513-519.
24. Orr P.T., Lewis M.C., Frick K.M. Dorsal hippocampal progesterone infusions enhance object recognition in young female mice. Pharm. Biochem. Behav. 2009, 93:177-182.
25. Park C.R. Permissive influence of stress in the expression of a U-shaped relationship between serum corticosterone levels and spatial memory errors in rats. Dose Response 2006, 4:55-75.
26. Sadri-Bakili G., Janis G.C., Pierce R.C., Gibbs T.T., Farb D.H. Nanomolar concentrations of pregnenolone sulfate enhance striatal dopamine overflow in vivo. J. Pharmacol. Exp. Ther. 2008, 327:840-845.
27. Schumacher M., Guennoun R., Ghoumari A., Massaad C., Robert F., El-Etr M., Akwa Y., Rajkowski K., Baulieu E. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr. Rev. 2007, 28:387-439.
28. Schumacher M., Liere P., Akwa Y., Rajkowski K., Griffiths W., Bodin K., Sjovall J., Baulieu E.-E. Pregnenolone sulfate in the brain: a controversial neurosteroid. Neurochem. Int. 2008, 52:522-540.
29. Shiraishi M., Shibuya I., Minami K., Uezono Y., Okamoto T., Yanagihara N., Ueno S., Ueta Y., Shigematsu A. A neurosteroid anesthetic, alphaxalone, inhibits nicotinic acetylcholine receptors in cultured bovine adrenal chromaffin cells. Anesth. Analg. 2002, 95:900-906.
30. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?. Trends Neurosci. 2001, 24:386-391.
31. Valée M., Mayo W., Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain. Res. Rev. 2001, 37:301-312.
32. Wang M.-D. The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intavenous infusion. J. Steroid Biochem. Mol. Biol. 1997, 62:299-306.
33. Zheng P. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog. Neurobiol. 2009, 89:134-152.